Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer
Clinical trial NCT01295086 · COMPLETED
Trial details
- NCT number
- NCT01295086
- Sponsor
- Odense University Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2014-11-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.